Health-care companies fell, but not by as much as the broad market, amid optimism about the outlook for drug sales next year. Eli Lilly and Novo Nordisk are likely to see strong demand for pill forms ...
A daily pill version of the weight-loss drug Wegovy shows significant weight reduction, greater convenience, and hope for making treatment accessible to millions of patients.
The Wegovy pill is expected to hit the market in January, joining injectable GLP-1 drugs that have transformed obesity treatment. One form you swallow, the other you inject. What else is different?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback